Cas:31895-22-4 Thiocyclam hydrogen oxalate manufacturer & supplier

Chemical Name:Thiocyclam hydrogen oxalate

CAS.NO:31895-22-4

Synonyms:MFCD00211369;oxalic acid—N,N-dimethyl-1,2,3-trithian-5-amine;Sulfoxane;san155i;NERISECT;thiocyclamhydrogeneoxalate;N,N-dimethyl-1,2,3-trithian-5-ylamine oxalate (1:1);san1551;san155;Thiocyclam hydrogen oxalate;Thiocyclam oxalate;EINECS 250-859-2;Thiocyclam hydrogenoxalate;Evisect;N,N-dimethyl-1,2,3-trithian-5-amine ethanedioate (1:1);evisekt

Molecular Formula:C₇H₁₃NO₄S₃

Molecular Weight:271.37700

HS Code:2934999090

Physical and Chemical Properties:

Melting point:125-128ºC

Boiling point:280.7ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:153.74000

Exact Mass:271.00100

LogP:1.11540

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:2588

Packing Group:III

Contact us for information like MFCD00211369 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,evisekt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,NERISECT Use and application,N,N-dimethyl-1,2,3-trithian-5-ylamine oxalate (1:1) technical grade,usp/ep/jp grade.

Related News: The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. Thiocyclam hydrogen oxalate manufacturer Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. Thiocyclam hydrogen oxalate supplier Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.�� Thiocyclam hydrogen oxalate vendor Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.�� Thiocyclam hydrogen oxalate factory Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.